Synergistic influence of polyoxometalate surface corona towards enhancing the antibacterial performance of tyrosine-capped Ag nanoparticles

被引:138
作者
Daima, Hemant K. [1 ]
Selvakannan, P. R. [1 ]
Kandjani, Ahmad E. [1 ]
Shukla, Ravi [1 ]
Bhargava, Suresh K. [1 ]
Bansal, Vipul [1 ]
机构
[1] RMIT Univ, Sch Appl Sci, CAMIC, NBRL, Melbourne, Vic 3000, Australia
基金
澳大利亚研究理事会;
关键词
SILVER NANOPARTICLES; ESCHERICHIA-COLI; GOLD NANOPARTICLES; IONS; AGENT; MODE;
D O I
10.1039/c3nr03806h
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
We illustrate a new strategy to improve the antibacterial potential of silver nanoparticles (AgNPs) by their surface modification with the surface corona of biologically active polyoxometalates (POMs). The stable POM surface corona was achieved by utilising zwitterionic tyrosine amino acid as a pH-switchable reducing and capping agent of AgNPs. The general applicability of this approach was demonstrated by developing surface coronas of phosphotungstic acid (PTA) and phosphomolybdic acid (PMA) around AgNPs. Our investigations on Gram negative bacterium Escherichia coli demonstrate that in conjugation with AgNPs, the surface corona of POMs enhances the physical damage to the bacterial cells due to synergistic antibacterial action of AgNPs and POMs, and the ability of tyrosine-reduced AgNPs (AgNPs(Y)) to act as an excellent carrier and stabiliser for the POMs. The further extension of this study towards Gram positive bacterium Staphylococcus albus showed a similar toxicity pattern, whereas these nanomaterials were found to be biocompatible for PC3 epithelial mammalian cells, suggesting the potential of these materials towards specific antimicrobial targeting for topical wound healing applications. The outcomes of this work show that facile tailorability of nanostructured surfaces may play a considerable role in controlling the biological activities of different nanomaterials.
引用
收藏
页码:758 / 765
页数:8
相关论文
共 37 条
[1]   Zirconia enrichment in zircon sand by selective fungus-mediated bioleaching of silica [J].
Bansal, Vipul ;
Syed, Asad ;
Bhargava, Suresh K. ;
Ahmad, Absar ;
Sastry, Murali .
LANGMUIR, 2007, 23 (09) :4993-4998
[2]   Nanosilver: A nanoproduct in medical application [J].
Chen, X. ;
Schluesener, H. J. .
TOXICOLOGY LETTERS, 2008, 176 (01) :1-12
[3]   The inhibitory effects of silver nanoparticles, silver ions, and silver chloride colloids on microbial growth [J].
Choi, Okkyoung ;
Deng, Kathy Kanjun ;
Kim, Nam-Jung ;
Ross, Louis, Jr. ;
Surampalli, Rao Y. ;
Hu, Zhiqiang .
WATER RESEARCH, 2008, 42 (12) :3066-3074
[4]  
Clement J L, 1994, Met Based Drugs, V1, P467, DOI 10.1155/MBD.1994.467
[5]  
Feng QL, 2000, J BIOMED MATER RES, V52, P662, DOI 10.1002/1097-4636(20001215)52:4<662::AID-JBM10>3.0.CO
[6]  
2-3
[7]   Polyoxometalates: Introduction to a class of inorganic compounds and their biomedical applications [J].
Hasenknopf, B .
FRONTIERS IN BIOSCIENCE-LANDMARK, 2005, 10 :275-287
[8]   HOMOGENEOUS CATALYSIS BY TRANSITION-METAL OXYGEN ANION CLUSTERS [J].
HILL, CL ;
PROSSERMCCARTHA, CM .
COORDINATION CHEMISTRY REVIEWS, 1995, 143 :407-455
[9]   Interaction of silver(I) ions with the respiratory chain of Escherichia coli:: An electrochemical and scanning electrochemical microscopy study of the antimicrobial mechanism of micromolar Ag [J].
Holt, KB ;
Bard, AJ .
BIOCHEMISTRY, 2005, 44 (39) :13214-13223
[10]   Antibacterial activity of highly negative charged polyoxotungstates, K27[KAs4W40O140] and K18[KSb9W21O86], and Keggin-structural polyoxotungstates against Helicobacter pylori [J].
Inoue, M ;
Segawa, K ;
Matsunaga, S ;
Matsumoto, N ;
Oda, M ;
Yamase, T .
JOURNAL OF INORGANIC BIOCHEMISTRY, 2005, 99 (05) :1023-1031